NASDAQ:SWAV

ShockWave Medical - SWAV Stock Forecast, Price & News

$264.27

+0.21 (+0.08%)

(As of 11/25/2022 12:00 AM ET)

Add

Compare

Today's Range: $261.67
▼
$265.00
50-Day Range: $242.79
▼
$296.82
52-Week Range: $113.36
▼
$320.54

Volume: 105,222 shs
Average Volume: 521,811 shs
Market Capitalization: $9.55 billion

P/E Ratio: 113.42
Dividend Yield: N/A
Price Target: $263.00

ShockWave Medical MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.63 Rating Score
Upside/Downside: 0.5% Downside
$263.00 Price Target
Short Interest: Healthy
4.12% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.55
Upright™ Environmental Score
News Sentiment: 0.49
Based on 14 Articles This Week
Insider Trading: Selling Shares
$15.20 M Sold Last Quarter
Proj. Earnings Growth: 23.61%
From $2.88 to $3.56 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.48 out of 5 stars

Medical Sector

97th out of 1,044 stocks

Surgical & Medical Instruments Industry

11th out of 104 stocks

1.3

Analyst's Opinion

Consensus Rating
ShockWave Medical has received a consensus rating of Buy. The company's average rating score is 2.63, and is based on 6 buy ratings, 1 hold rating, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $263.00, ShockWave Medical has a forecasted downside of 0.5% from its current price of $264.27.
Amount of Analyst Coverage
ShockWave Medical has only been the subject of 4 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
4.12% of the outstanding shares of ShockWave Medical have been sold short.
Short Interest Ratio / Days to Cover
ShockWave Medical has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in ShockWave Medical has recently decreased by 10.78%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
ShockWave Medical does not currently pay a dividend.
Dividend Growth
ShockWave Medical does not have a long track record of dividend growth.

4.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
ShockWave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.
Environmental Sustainability
The Environmental Impact score for ShockWave Medical is -0.55.

2.5

News and Social Media Coverage

News Sentiment
ShockWave Medical has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 14 news articles for ShockWave Medical this week, compared to 4 articles on an average week.
Search Interest
27 people have searched for SWAV on MarketBeat in the last 30 days. This is an increase of 80% compared to the previous 30 days.
MarketBeat Follows
Only 11 people have added ShockWave Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ShockWave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,199,064.00 in company stock.
Percentage Held by Insiders
Only 3.90% of the stock of ShockWave Medical is held by insiders.
Percentage Held by Institutions
95.40% of the stock of ShockWave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for ShockWave Medical are expected to grow by 23.61% in the coming year, from $2.88 to $3.56 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of ShockWave Medical is 113.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.63.
Price to Earnings Ratio vs. Sector
The P/E ratio of ShockWave Medical is 113.42, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 150.09.
Price to Book Value per Share Ratio
ShockWave Medical has a P/B Ratio of 26.83. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About ShockWave Medical (NASDAQ:SWAV) Stock

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Stock News Headlines

November 24, 2022 | finance.yahoo.com

3 Medical Instruments Stocks to Buy as Inflation Clouds Prospects

November 24, 2022 | americanbankingnews.com

ShockWave Medical, Inc. (NASDAQ:SWAV) Receives $263.00 Average PT from Analysts

November 23, 2022 | finance.yahoo.com

PerkinElmer's (PKI) New Viral Vector Assays to Boost Workflows

November 23, 2022 | americanbankingnews.com

ShockWave Medical, Inc. (NASDAQ:SWAV) CFO Sells $271,656.00 in Stock

November 23, 2022 | finance.yahoo.com

3 Beaten-Down Growth Stocks That Billionaires Are Buying With Both Hands

November 22, 2022 | finance.yahoo.com

Shockwave Medical to Participate in the Piper Sandler 34th Annual Healthcare Conference

November 22, 2022 | finance.yahoo.com

Merit Medical's (MMSI) New Launch to Boost Patient Outcome

November 22, 2022 | finance.yahoo.com

Here's Why You Should Hold on to Abiomed (ABMD) Stock Now

November 22, 2022 | finance.yahoo.com

Medtronic (MDT) Q2 Earnings Beat Estimates, Margins Down

November 21, 2022 | americanbankingnews.com

Insider Selling: ShockWave Medical, Inc. (NASDAQ:SWAV) Director Sells $733,320.00 in Stock

November 18, 2022 | finance.yahoo.com

Neogen's (NEOG) Synergize Disinfectant Now Widely Available

November 13, 2022 | finance.yahoo.com

We Think ShockWave Medical (NASDAQ:SWAV) Might Have The DNA Of A Multi-Bagger

November 11, 2022 | finance.yahoo.com

Patterson Companies (PDCO) Inks Deal to Expand Product Suite

November 8, 2022 | finance.yahoo.com

Will ShockWave Medical (SWAV) Continue to Beat its Earnings Estimates?

November 8, 2022 | finance.yahoo.com

Shockwave Medical (SWAV) Beats on Q3 Earnings & Revenues

November 7, 2022 | seekingalpha.com

ShockWave Medical, Inc. (SWAV) Q3 2022 Earnings Call Transcript

November 7, 2022 | finance.yahoo.com

Shockwave Medical Reports Third Quarter 2022 Financial Results

November 7, 2022 | finance.yahoo.com

Shockwave Medical (SWAV) Q3 Earnings and Revenues Beat Estimates

November 7, 2022 | finance.yahoo.com

ShockWave Medical (SWAV) Q3 2022 Earnings Call Transcript

November 4, 2022 | msn.com

Earnings Preview: ShockWave Medical

November 4, 2022 | finance.yahoo.com

What's in Store for Shockwave Medical (SWAV) in Q3 Earnings?

November 1, 2022 | finance.yahoo.com

Shockwave Medical (SWAV) Stock Moves -0.38%: What You Should Know

November 1, 2022 | finance.yahoo.com

Shockwave Confirms Consistent Outcomes for IVL in the Largest Prospective “Real World” Study of Patients with Heavily Calcified Peripheral Arterial Disease

October 31, 2022 | finance.yahoo.com

Here’s Why ShockWave Medical (SWAV) Outperformed in the Third Quarter

October 26, 2022 | finance.yahoo.com

Shockwave Medical (SWAV) Stock Jumps 6%: Will It Continue to Soar?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Company Calendar

Last Earnings: 11/08/2021
Today: 11/25/2022
Fiscal Year End: 12/31/2022
Next Earnings (Estimated): 2/16/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SWAV
CUSIP: N/A
CIK: 1642545
Web: www.shockwavemedical.com
Phone: (510) 279-4262
Fax: N/A
Employees: 657
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $263.00
High Stock Price Forecast: $338.00
Low Stock Price Forecast: $165.00
Forecasted Upside/Downside: -0.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.63
Research Coverage: 8 Analysts

Profitability

EPS (Most Recent Fiscal Year): $2.33
Trailing P/E Ratio: 113.42
Forward P/E Ratio: 91.76
P/E Growth: N/A
Net Income: $-9,140,000.00
Net Margins: 20.48%
Pretax Margin: 20.75%
Return on Equity: 30.08%
Return on Assets: 21.85%

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 7.29
Quick Ratio: 6.02

Sales & Book Value

Annual Sales: $237.15 million
Price / Sales: 40.28
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $9.85 per share
Price / Book: 26.83

Miscellaneous

Outstanding Shares: 36,142,000
Free Float: 34,732,000
Market Cap: $9.55 billion
Optionable: Not Optionable
Beta: 1.03

Key Executives

Mr. Douglas E. Godshall M.B.A. (Age 57)
Pres, CEO & Director
Comp: $1.4M

Mr. Daniel Puckett MBA (Age 58)
CFO, Principal Financial Officer & Sec.
Comp: $658.71k

Mr. Isaac Zacharias (Age 47)
Chief Commercial Officer
Comp: $679.54k

Mr. Daniel Hawkins (Age 55)
Founder and Sr. Advisor

Mr. John M. Adams (Age 75)
Co-Founder and Technical Advisor

Mr. Mike Maszy
VP of Operations

Ms. Trinh Phung (Age 44)
Chief Accounting Officer, Principal Accounting Officer & VP of Fin.

Ms. Debbie Kaster
VP of Investor Relations

Mr. Hajime Tada J.D.
Gen. Counsel & Sec.

Mr. Rob Williamson Jr.
VP of Sales

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SWAV Stock - Frequently Asked Questions

Should I buy or sell ShockWave Medical stock right now?: 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ShockWave Medical in the last twelve months. There are currently 1 sell rating, 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SWAV shares.
View SWAV analyst ratings or view top-rated stocks.
What is ShockWave Medical's stock price forecast for 2023?: 8 Wall Street analysts have issued 12-month price targets for ShockWave Medical's shares. Their SWAV share price forecasts range from $165.00 to $338.00. On average, they anticipate the company's share price to reach $263.00 in the next twelve months. This suggests that the stock has a possible downside of 0.5%.
View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts.
How have SWAV shares performed in 2022?: ShockWave Medical's stock was trading at $178.33 at the beginning of 2022. Since then, SWAV stock has increased by 48.2% and is now trading at $264.27.
View the best growth stocks for 2022 here.
When is ShockWave Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our SWAV earnings forecast.
How were ShockWave Medical's earnings last quarter?: ShockWave Medical, Inc. (NASDAQ:SWAV) posted its quarterly earnings data on Monday, November, 8th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.12. The company earned $65.16 million during the quarter, compared to analysts' expectations of $61.21 million. ShockWave Medical had a net margin of 20.48% and a trailing twelve-month return on equity of 30.08%. ShockWave Medical's revenue for the quarter was up 232.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.38) earnings per share.
What guidance has ShockWave Medical issued on next quarter's earnings?: ShockWave Medical issued an update on its FY 2022 earnings guidance on Monday, November, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $483.00 million-$488.00 million, compared to the consensus revenue estimate of $475.94 million.
What is Doug Godshall's approval rating as ShockWave Medical's CEO?: 8 employees have rated ShockWave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.

What other stocks do shareholders of ShockWave Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ShockWave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).
When did ShockWave Medical IPO?: (SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.
What is ShockWave Medical's stock symbol?: ShockWave Medical trades on the NASDAQ under the ticker symbol "SWAV."
Who are ShockWave Medical's major shareholders?: ShockWave Medical's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (12.18%), Vanguard Group Inc. (9.77%), Price T Rowe Associates Inc. MD (4.97%), State Street Corp (3.20%), Macquarie Group Ltd. (2.67%) and Artisan Partners Limited Partnership (1.85%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sofinnova Capital Vii Fcpr and Trinh Phung.
View institutional ownership trends.
How do I buy shares of ShockWave Medical?: Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is ShockWave Medical's stock price today?: One share of SWAV stock can currently be purchased for approximately $264.27.
How much money does ShockWave Medical make?: ShockWave Medical (NASDAQ:SWAV) has a market capitalization of $9.55 billion and generates $237.15 million in revenue each year. The company earns $-9,140,000.00 in net income (profit) each year or $2.33 on an earnings per share basis.
How many employees does ShockWave Medical have?: The company employs 657 workers across the globe.
How can I contact ShockWave Medical?: ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (510) 279-4262 or via email at investors@shockwavemedical.com.

This page (NASDAQ:SWAV) was last updated on 11/26/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ShockWave Medical - SWAV Stock Forecast, Price & News

ShockWave Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About ShockWave Medical (NASDAQ:SWAV) Stock

SWAV Stock News Headlines

SWAV Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

SWAV Stock - Frequently Asked Questions

Overall MarketRank^™